Cpi 613

Cpi 613

SCHEMBL26613605

[2H]C([2H])(CC(=O)O)C([2H])([2H])CC(CCSCc1ccccc1)SCc1ccccc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.55
▸ PTGER1 P34995 1/20 0.45
▸ PTGER4 P35408 1/20 0.45
▸ PTGER3 P43115 1/20 0.45
▸ PTGER2 P43116 1/20 0.45
▸ HPGD P15428 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ FOLH1 Q04609 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CPA3 P15088 1/20 0.36
▸ MMP1 P03956 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP3 P08254 1/20 0.36
▸ MMP7 P09237 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ KEAP1 Q14145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cpi 613 SCHEMBL26613507 0.91 CYP2C19 (0.54) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL20395792 0.88 CYP2C19 (0.63) CYP2C19PTGER1PTGER4PTGER3PTGER2
Cpi 613 SCHEMBL1062218 0.85 CYP2C19 (0.59) CYP2C19PTGER1PTGER4PTGER3PTGER2
Cpi 613 SCHEMBL13333201 0.85 CYP2C19 (0.59) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL17381514 0.84 CYP2C19 (0.58) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL26613554 0.84 CYP2C19 (0.50) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL22299081 0.84 CYP2C19 (0.58) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL20395088 0.80 CYP2C19 (0.56) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL13333202 0.78 CYP2C19 (0.50) CYP2C19PTGER1PTGER4PTGER3PTGER2
SCHEMBL26613581 0.78 CYP2C19 (0.42) CYP2C19HPGDALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348373-A1 DEUTERATED DERIVATIVES OF 6,8-BIS(BENZYLSULFANYL)OCTANOIC ACID RAFAEL PHARMACEUTICALS, INC. (US) 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348373-A1 DEUTERATED DERIVATIVES OF 6,8-BIS(BENZYLSULFANYL)OCTANOIC ACID SCD5, DHCR7, BCL6 CYP2C19 1131/4885PTGER1 1799/4885PTGER4 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback